Total Payments
$2,202
2024 Payments
$1,011
Companies
27
Transactions
82
Payment Breakdown by Category
Food & Beverage$1,546 (70.2%)
Education$655.87 (29.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,546 | 75 | 70.2% |
| Education | $655.87 | 7 | 29.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SEAGEN INC. | $352.61 | 6 | $0 (2024) |
| Incyte Corporation | $210.02 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $196.47 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $188.38 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $151.67 | 4 | $0 (2024) |
| PFIZER INC. | $142.48 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $102.21 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $98.94 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $81.99 | 1 | $0 (2022) |
| Amgen Inc. | $67.02 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,011 | 44 | Novartis Pharmaceuticals Corporation ($196.47) |
| 2023 | $731.42 | 25 | Seagen Inc. ($137.68) |
| 2022 | $459.37 | 13 | Seagen Inc. ($114.98) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Hematology/Oncology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Oncology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.98 | General |
| 09/27/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $42.06 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Hematology | ||||||
| 08/19/2024 | SEAGEN INC. | — | Education | In-kind items and services | $99.95 | General |
| 08/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Rare Disease | ||||||
| 08/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Oncology | ||||||
| 07/20/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Immunology | ||||||
| 07/08/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Hematology | ||||||
| 06/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ONCOLOGY | ||||||
About Dr. Marcus Trybula, MD
Dr. Marcus Trybula, MD is a Hematology & Oncology healthcare provider based in Lebanon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1487114989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Trybula, MD has received a total of $2,202 in payments from pharmaceutical and medical device companies, with $1,011 received in 2024. These payments were reported across 82 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,546).
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Lebanon, OH
- Active Since 03/21/2019
- Last Updated 09/08/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1487114989
Products in Payments
- JAKAFI (Drug) $105.68
- JEVTANA (Drug) $102.27
- KEYTRUDA (Biological) $102.21
- Fabhalta (Drug) $101.45
- IBRANCE (Drug) $65.30
- AYVAKIT (Drug) $61.87
- Lenvima (Drug) $55.83
- IMBRUVICA (Drug) $52.78
- REBLOZYL (Biological) $51.43
- MEKINIST (Drug) $48.18
- LYNPARZA (Drug) $47.46
- Enhertu (Drug) $45.25
- INLYTA (Drug) $42.68
- ULTOMIRIS (Biological) $38.93
- ICLUSIG (Drug) $38.80
- IMFINZI (Biological) $35.10
- Xospata (Drug) $33.57
- BRAFTOVI (Drug) $32.70
- ADCETRIS (Biological) $32.57
- KISQALI (Drug) $31.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lebanon
Frederick Lansigan, M.d, M.D
Hematology & Oncology — Payments: $56,556
Hematology & Oncology $56,556
Kenneth Meehan, Md, MD
Hematology & Oncology — Payments: $8,961
Hematology & Oncology $8,961
Dr. Charles Gaulin
Hematology & Oncology — Payments: $6,655
Hematology & Oncology $6,655
Konstantin Dragnev, Md, MD
Hematology & Oncology — Payments: $5,771
Hematology & Oncology $5,771
Dr. John Hill, M.d, M.D
Hematology & Oncology — Payments: $624.07
Hematology & Oncology $624.07
Dr. Marianne Spengler, M.d, M.D
Hematology & Oncology — Payments: $609.38
Hematology & Oncology $609.38